The first-evr BMW 3.0 CLS is now for sale for the first time since it saw the light of day. The model is for sale for the ...

Australia’s largest drugmaker CSL Ltd. is committing roughly $1.5 billion to expand its US manufacturing footprint, joining a wave of pharmaceutical giants doubling down on American production.

The global biotech is promising to create American jobs but has not said where its new plasma therapy manufacturing site will be located.

Alongside the U.S. government’s overhaul of the federal vaccine infrastructure, influenza vaccination rates in the country have plummeted below the expectations of a key player in the space. That ...

In a move to diversify its business, Australian biopharma CSL has agreed to acquire Vifor Pharma for $11.7 billion. The deal would give CSL—heavily dependent on vaccines and blood plasma ...

Victor is a Mechanical Engineer and certified auto mechanic from Portugal. He specializes in automotive technology and maintenance. His articles are informational and educational, bringing to light ...

Donors have funded hundreds of emergency shelter nights during the Community Services League's Giving Tuesday campaign.

Australia has taken a major step forward in onshore vaccine production with the opening of CSL's manufacturing facility in ...

The very first BMW 3.0 CSL, a development car, is up for sale.

With hindsight, it's clear that the early 2000s were a high point for BMW. Cars like this, the 2004 M3 CSL prove it. The E46-generation M3 was already a great car, but with the CSL, the engineers at ...